Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Leading industrial gas company Air Products and Chemicals Inc. (APD - Analyst Report) recently said that it will feature its chemistry and thin film deposition capabilities at the ongoing AVS Atomic Layer Deposition (“ALD”) annual meeting in Dresden, Germany.
The company’s representatives at the ALD 2012 will make several presentations both independently and jointly with external partners. These include oral presentation on atomic layer deposition (ALD) of GST layers for phase change memories and ALD of strontium oxide and titanate using novel imidazolate precursors. There will also be poster presentations on collaborative works with R&D partners.
ALD is a thin film deposition technology which uses special chemicals (“precursors”) to fabricate thin film structures for many semiconductors. The ALD meet has gained importance over the last few years as the ALD technology is capable of addressing the challenges associated with manufacturing several advanced semiconductor devices.
Air Products, which had sales of $10.1 billion in 2011, offers industrial gases as well as a variety of polymer and performance chemicals and serves technology, energy, industrial and health care customers globally. The company competes with Praxair Inc. (PX - Analyst Report), among others.
Air Products has been investing heavily in developing chemical precursors and ALD deposition tools. The company’s dedicated teams of chemists have been engaged in developing precursors which are tested in various ALD tools in laboratories in Korea and California.
Air Products benefits from a long-term take-or-pay contract, a consolidated industry structure, diverse customer base and sustained pricing power. The company’s healthy project backlog and solid bidding activity strongly position it to achieve its long-term growth target.
However, soaring energy and raw material costs pose a threat to margin expansion. Moreover, sluggish economic conditions across the U.S. and Europe may impact the demand for the company’s products in the second half of fiscal 2012.
We currently have a long-term Neutral recommendation on Air Products. The stock retains a Zacks #4 Rank, which translates into a short-term Sell recommendation.
Get the full Analyst Report on APD - FREE
Get the full Analyst Report on PX - FREE